Neuraline
Back to BlogClinical Reference

GAD-7 & PHQ-9 Score Interpretation: Cutoffs & CPT 96127

Neuraline TeamNovember 16, 20268 min read

Quick answer: PHQ-9 scores 0–27 (0–4 minimal, 5–9 mild, 10–14 moderate, 15–19 moderately severe, 20–27 severe) and GAD-7 scores 0–21 (0–4 minimal, 5–9 mild, 10–14 moderate, 15–21 severe). A score ≥10 on either is the validated positive-screen cutoff for major depression or generalized anxiety disorder — it triggers clinical interview, not an automatic diagnosis.

GAD-7 cutoff bands at a glance: 0–4 Minimal — routine care, rescreen annually · 5–9 Mild — watchful waiting, rescreen in 2–4 weeks · 10–14 Moderate — positive screen: clinical interview + treatment plan · 15–21 Severe — active treatment, consider referral. Any score ≥10 is the validated positive-screen cutoff — it triggers clinical intervention and, when documented in the encounter, supports CPT 96127 billing.

Interactive Screening Calculator

PHQ-9 · GAD-7 · PHQ-2 — live scoring, no signup

PHQ-9 — Depression (9 items, 0–27)

1. Little interest or pleasure in doing things

2. Feeling down, depressed, or hopeless

3. Trouble falling or staying asleep, or sleeping too much

4. Feeling tired or having little energy

5. Poor appetite or overeating

6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down

7. Trouble concentrating on things

8. Moving or speaking so slowly others noticed, or being so fidgety/restless you have been moving around a lot more than usual

9. Thoughts that you would be better off dead, or of hurting yourself in some way

0/9 answered

GAD-7 — Anxiety (7 items, 0–21)

1. Little interest or pleasure in doing things

2. Feeling down, depressed, or hopeless

3. Trouble falling or staying asleep, or sleeping too much

4. Feeling tired or having little energy

5. Poor appetite or overeating

6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down

7. Trouble concentrating on things

0/7 answered

PHQ-9 Total

0/27
Minimal depressionScreen negative

Suggested ICD-10-CM if criteria met: F32.9/F33.9 · CPT 96127 billable when staff-administered & scored

GAD-7 Total

0/21
Minimal anxietyScreen negative

Suggested ICD-10-CM if criteria met: F41.1 · CPT 96127 billable when staff-administered & scored

Educational tool — not a diagnosis. Results require interpretation by a qualified clinician. This screen does not replace the DSM-5-TR clinical interview.

Why Score Interpretation Gets Searched — and How to Use This Guide

Clinicians search PHQ-9/GAD-7 interpretation for three reasons: they need the severity band for a score in front of them (the MDCalc-style lookup), they need to document what the score means in a note that survives audit, and they need to know what to do next — rescreen, treat, or refer. Spanish-language administration is the fourth driver: with Spanish the second-most-spoken language in US clinical settings, validated Spanish forms and comparable scoring are a daily workflow question.

Use the interactive calculator above for live scoring; use the tables below for the interpretation and documentation layer. The two are designed to work together — score in the calculator, document with the snippets, bill with the CPT rules.

Severity Bands at a Glance

ScorePHQ-9 (0–27)GAD-7 (0–21)Action
Minimal0–40–4Routine care; rescreen annually
Mild5–95–9Watchful waiting; lifestyle measures; rescreen in 2–4 weeks
Moderate10–1410–14Positive screen — clinical interview + treatment
Mod. severe / Severe15–19 (mod-severe), 20–27 (severe)15–21 (severe)Active treatment — therapy, medication, or both

The ≥10 Cutoff — What It Actually Means

PropertyPHQ-9GAD-7
Positive cutoff≥10≥10
Sensitivity~88%~89%
Specificity~88%~82%
Validated in3,000+ primary care patients (Kroenke 2001)~2,740 primary care patients (Spitzer 2006)
What it flagsMajor depressive disorderGeneralized anxiety disorder (+ any anxiety disorder)

A positive screen is not a diagnosis. The DSM-5-TR interview establishes criteria — duration, functional impairment, exclusions. Document screen result and interview findings as separate data points.

Combined PHQ-9 + GAD-7 Interpretation

PHQ-9GAD-7InterpretationTypical presentation
≥10≥10Comorbid depression + anxietyMost common behavioral health presentation; assess both
≥105–9Depression with mild anxietyDepression-primary treatment pathway
5–9≥10Anxiety with mild depressionAnxiety-primary; monitor mood
10–1410–14Moderate bothCombined treatment planning
<5<5Neither screen positiveRoutine care

Item 9 — The Suicide Flag

Any PHQ-9 item-9 score ≥1 triggers mandatory suicide risk assessment — regardless of total score. A patient scoring 3 overall with item 9 = 1 still needs the C-SSRS or equivalent triage. Never document "PHQ-9 negative" without checking item 9 separately.

Spanish-Language Administration (PHQ-9 / GAD-7 en Español)

Both instruments have validated Spanish translations with equivalent psychometric properties — scores are comparable across languages. Key notes:

ConsiderationGuidance
Validated versionsUse the official Kroenke/Spitzer Spanish translations, not ad-hoc translations
Cultural expressionSomatic idioms of distress ("nervios," "dolor de cabeza") may load differently — pair scores with interview
Interpreter useSelf-report works better than interpreter-administered; validated Spanish forms preferred
DocumentationRecord language of administration in the note

Billing: CPT 96127 for Administration & Scoring

RuleDetail
CodeCPT 96127 — psychological/neuropsychological test administration + scoring by staff under QHP supervision
TimePer hour of staff time; 16-minute minimum; 1 unit typically covers a screening session
FrequencyMost payers: 1 unit per patient per day
Same-day E/MBillable alongside E/M — document separately
DocumentationInstrument, date, raw score, severity interpretation, staff time, supervising provider
Reimbursement~$1–2 per unit (varies by payer)

Score Change During Treatment — MCID and Response Thresholds

The minimum clinically important difference (MCID) is the score change a patient actually feels:

InstrumentMCIDWhat it means
PHQ-9≥5-point dropClinically meaningful improvement — treatment is working
GAD-7≥4-point dropClinically meaningful improvement
PHQ-9≥50% reductionResponse (remission threshold: total ≤4)
GAD-7≥50% reductionResponse (remission threshold: total ≤4)
TrajectoryDecision
≥MCID drop by week 4–6Continue current plan
Partial dropOptimize dose, intensify therapy, or add measurement-based follow-up
No change after adequate trialSwitch agent or modality — document the trial and the score that justified the switch

PHQ-2 and GAD-2 — Primary Care Pre-Screening

The first two items of each instrument form ultra-brief pre-screens for time-constrained visits:

Pre-screenItemsRangePositive thresholdNext step
PHQ-2Anhedonia + depressed mood0–6≥3Administer full PHQ-9
GAD-2Nervous/on edge + uncontrollable worry0–6≥3Administer full GAD-7

Both trade some sensitivity for speed — appropriate for annual wellness visits and busy intake, not for tracking treatment response.

The PHQ-A Adolescent Variant (Ages 11–17)

The PHQ-A modifies PHQ-9 wording for adolescents with identical 0–27 scoring and severity bands. Two adolescent-specific cautions: irritability may present instead of depressed mood, and item 9 carries elevated weight — adolescent endorsement of item 9 warrants immediate C-SSRS administration and same-visit safety planning.

Measurement-Based Care Protocol

  1. Baseline — PHQ-9 + GAD-7 at intake (portal or encounter)
  2. Follow-up — repeat every 2–4 weeks during active treatment
  3. Interpret — apply MCID thresholds; document score, band, and trajectory
  4. Decide — continue, optimize, or switch based on the trajectory table above
  5. Document — the score trail is the medical-necessity record payers audit

Related Resources

Clinical Documentation Snippet

PHQ-9 administered today (past 2 weeks): total 14/27 — moderate depression (positive screen ≥10). GAD-7: 8/21 — mild anxiety (negative screen). PHQ-9 item 9 = 0, no suicide risk flag. Scores consistent with moderate depressive symptoms; clinical interview scheduled to establish DSM-5-TR criteria. Patient prefers Spanish-language forms for future administrations. CPT 96127 billed for staff administration and scoring.

Frequently Asked Questions

Is a PHQ-9 score of 10 automatically a depression diagnosis?

No — it is a positive screen. The ≥10 cutoff identifies patients needing a DSM-5-TR clinical interview; diagnosis additionally requires duration (2-week episode), functional impairment, and exclusion of substance/medical causes. Document the screen and the interview separately.

What does a PHQ-9 score of 15 mean?

15–19 is the moderately severe band — active treatment is indicated (psychotherapy, medication, or both), and suicide-risk assessment is required if item 9 is endorsed. A score of 15 supports medical necessity for structured treatment and higher-complexity E/M documentation.

Can PHQ-9 and GAD-7 be given in Spanish?

Yes — both have validated Spanish translations with equivalent psychometrics; scores are comparable across languages. Use official translations (not ad-hoc), record the language of administration, and pair scores with clinical interview since somatic idioms of distress may load differently.

How often should PHQ-9 be repeated during treatment?

Every 2–4 weeks during active treatment. A ≥5-point drop is the clinically meaningful improvement threshold; a total ≤4 indicates remission. Serial scores are the measurement-based-care record that supports continued treatment authorization.


This guide summarizes PHQ-9 and GAD-7 score interpretation for clinical reference. Screening scores require clinical interpretation — they are not diagnoses.

Score PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, and MMSE automatically in Neuraline — with AI interpretation and 3-click AI Charting. Explore the screening module or book a demo.

About Neuraline

Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.

Follow Neuraline on LinkedIn

See Neuraline in Action

Ready to transform your practice with AI-powered EHR? Schedule a personalized demo today.

Request Your Demo